Return to Results

Treatment of Early Nasal Polyposis With Topical Triamcinolone

new search

Trial Conditions
  • Nasal Polyps
What is the purpose of this trial?

The purpose of this study is to compare the effectiveness of intranasal Triamcinolone delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked dressing, in the treatment and prevention of early nasal polyposis.

Date & Status

Recruiting

Who can Participate?

Eligibility

Ages:
18 and older

Gender:
Both

Eligibility

Inclusion Criteria:

- Age > 18 years

- Patients with early nasal polyposis

Exclusion Criteria:

- Age < 18 years

- Patients with active sinus infections

- Patients on long term steroids

- Allergy or sensitivity to steroids

- Patients with Antrochoanal polyps

- Patients who received topical steroids by bio-resorbable sponge or oral steroids

Gender: Both
Steward Physician(s)
  • Peter Catalano, MD
Trial Interventions
Drug
  • Triamcinolone
  • Triamcinolone
Physician Researcher

Investigator Name:

  • Peter Catalano, MD

Other Information

Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.
Phase: Phase 2
Trial ID: NCT01222871
Volunteers:  Not Accepting Healthy Volunteers

new search

Connect with Steward

Visit Our Twitter Feed Visit Our Facebook Page Email This Page Print This Page

Subscribe to our patient e-newsletter

Copyright © 2014 Steward Health Care
Connect Healthcare Panacea CMS Solutions